SanoLiBio GmbH

Developing a fully automated circulating tumor cell (CTC) enrichment platform. Our Cell Enricher Single benchtop device will be introduced from 2019 onwards. It enables physicians and scientists to diagnose cancer at its earliest stage, perform reliable prognostic or to apply individualized treatment.